N
News Analysis
tickerreport.com

www.tickerreport.com ·

Positive

reviewing amn healthcare services nyseamn and progyny nasdaqpgny

TAX_ECON_PRICETAX_FNCACT_PHARMACISTSTAX_FNCACT_VENDORTAX_FNCACT_PHYSICIAN

All NewsRead the full story on tickerreport.com

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.

AI insight

AI-generated

The article compares two US healthcare staffing/fertility benefits companies based on financial metrics and analyst targets. No concrete commercial mechanism, supply chain disruption, or regulatory change is reported. The impact is limited to equity valuation differentials between AMN and PGNY, with no broader sector or commodity effect.

Signals our AI researcher identified

Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.

  • Progyny net margin 5.23% vs AMN -0.95%
  • Progyny EPS $0.77 vs AMN -$0.87
  • AMN revenue $2.73B vs Progyny $1.29B
  • Progyny target price $28.55 (22.78% upside)
  • AMN target price $25.29 (11.54% downside)

About the publisher

tickerreport.com is one of the en-language news outlets that News Analysis aggregates. Coverage from this source appears in our global feed alongside the publisher's own reporting.

Topic context

tickerreport.com files this story under "tax econ price" in the GDELT knowledge graph. News Analysis surfaces coverage based on the same open classification taxonomy.

reviewing amn healthcare services nyseamn and progyny nasdaqpgny | tickerreport.com — News Analysis